Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2002
12/12/2002WO2002074923A9 Targets and screens for agents useful in controlling parasitic nematodes
12/12/2002WO2002074798A3 The genome of a bifidobacterium
12/12/2002WO2002070552A3 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
12/12/2002WO2002068623A3 Genes encoding proteolytic enzymes from aspargilli
12/12/2002WO2002067984A3 Materials and methods for detecting, preventing, and treating hiv and fiv retroviral infection
12/12/2002WO2002065123A3 Biochemical method and apparatus for detecting protein characteristics
12/12/2002WO2002064829A3 Biochemical method and apparatus for detecting genetic characteristics
12/12/2002WO2002064161A3 Method and compositions for immunization with the pseudomonas v antigen
12/12/2002WO2002062967A3 Multipotent o-2a progenitors from the neurohypophysis
12/12/2002WO2002062297A9 Methods and compositions for modulating gluconeogenesis using pgc-1
12/12/2002WO2002061144A8 Brain tumor diagnosis and outcome prediction
12/12/2002WO2002061052A3 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
12/12/2002WO2002059612A3 Animal model and cell-line expressing modified chlorine channel
12/12/2002WO2002058947A3 A method of wear testing a tire
12/12/2002WO2002058534A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/12/2002WO2002057737A3 Method for separating proteins by capillary electrophoresis and buffer compositions for capillary electrophoresis
12/12/2002WO2002057736A3 Method for capillary electrophoresis in free solution with an alkaline ph
12/12/2002WO2002053723A3 Degradation and detection of tse infectivity
12/12/2002WO2002050106A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
12/12/2002WO2002046404A3 Schizophrenia-related voltage-gated ion channel gene and protein
12/12/2002WO2002046232A3 Multimeric single-chain antibody with multiple antigen binding
12/12/2002WO2002044718A3 S.aureus protein staau r2, gene encoding it and uses thereof
12/12/2002WO2002042773B1 An extended tethering approach for rapid identification of ligands
12/12/2002WO2002035238A8 Method of determining prion strain
12/12/2002WO2002034891A3 Immortalized preosteoblasts and method for their production
12/12/2002WO2002031496A3 Device for determining skin aging in vitro
12/12/2002WO2002029408A3 Methods for diagnosing and treating huntington's disease
12/12/2002WO2002024749A3 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/12/2002WO2002022853A3 Method for measuring the activity of the blood clotting factor xiiia
12/12/2002WO2002018557A3 Human kinases
12/12/2002WO2002008723A3 Method for the selective determination of blocking auto-antibodies to the tsh receptor
12/12/2002WO2001098779A3 Methods of identifying gabab receptor subtype-specific agonists
12/12/2002WO2001095233A9 Analysis of data from liquid chromatographic separation of dna
12/12/2002WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002WO2001089788A9 Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks
12/12/2002WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002WO2001020593A9 System and method for programmable illumination pattern generation
12/12/2002WO2001018207A9 Human 7tm proteins receptors and polynucleotides encoding the same
12/12/2002WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis
12/12/2002US20020188961 Non human transgenic animal in which the expression of the gene coding for insulin is deleted
12/12/2002US20020188408 Clearinghouse methods and systems for processing bioinformatic data
12/12/2002US20020188224 Test media cassette for bodily fluid testing device
12/12/2002US20020188221 Percutaneous biological fluid constituent sampling and measurement devices and methods
12/12/2002US20020188212 High throughput biological heart rate monitor that is molecularly determined
12/12/2002US20020188185 Percutaneous biological fluid sampling and analyte measurement devices and methods
12/12/2002US20020188184 Percutaneous biological fluid sampling and analyte measurement devices and methods
12/12/2002US20020188111 For photodynamic therapy of a lesion; medical diagnosis; drug screening; bioavailability
12/12/2002US20020188108 Detection of ribosome binding protein; obtain ribosome, incubate with binding protein, detect formation of ribosome complex
12/12/2002US20020188106 Tau protein epitopes for use in the treatment of alzheimer's disease
12/12/2002US20020188052 Barium ferrite filler; magnetic tapes
12/12/2002US20020187997 Phospholipid transfer protein (PLTP) and cholesterol metabolism
12/12/2002US20020187953 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
12/12/2002US20020187949 High throughput biological heart rate monitor that is molecularly determined
12/12/2002US20020187947 Inflammation-related gene
12/12/2002US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002US20020187931 Modulating cell survival by modulating huntingtin function
12/12/2002US20020187930 Substances and their uses
12/12/2002US20020187922 Novel molecules of the pyrin domain protein family and uses thereof
12/12/2002US20020187921 Transgenic zebrafish models for neurodegenerative disease
12/12/2002US20020187583 Method for manufacturing a hydrogen gas sensor
12/12/2002US20020187563 Diagnostic neodymium(iii), ytterbium(iii), or erbium(iii) ion-ligand complexes
12/12/2002US20020187562 Chromatographic material for use in the detection of drugs in sample
12/12/2002US20020187561 Apparatus for use as analytical and diagnostic tool in analysis of biological fluids
12/12/2002US20020187559 Chemical analysis of preefrential fluid sample; obtain fluid sample, trap a segment in absorder material, detect components of fluid sample
12/12/2002US20020187558 Detecting metal concentration in water; obtain water, incubate with solid material, removel slid material, elute metal from solid material, detect colorimetric signal
12/12/2002US20020187556 Biological fluid constituent sampling and measurement devices and methods
12/12/2002US20020187554 Control serum for dry analytical element
12/12/2002US20020187550 Generation of genetically engineered cells; obtain embryonic stem cells, culture, incubate with cytokine, recover differentiated cells
12/12/2002US20020187544 Uropathogenic E. coli D-serine detoxification operon
12/12/2002US20020187534 Treating cancer by increasing intracellular malonyl CoA levels
12/12/2002US20020187523 Extracellular signaling molecules
12/12/2002US20020187520 Allergen/ inflammatory testing and diagnosis
12/12/2002US20020187518 Determining the concentration of prostate specific antigen in sample; obtain sample, incubate with immunoprecipaate agent, determine concentration of prostate specific antigen
12/12/2002US20020187517 Monoclonal antibodies to Sarcocystis neurona and uses therefor
12/12/2002US20020187516 Assay for evaluation of cellular response to allergens
12/12/2002US20020187515 Composite arrays utilizing microspheres
12/12/2002US20020187513 Monitoring preferential reaction in microfluidic system; obtain sample, incubate with substrate, determine concentration of reaction product in assay
12/12/2002US20020187512 Crystal structure of human interleukin-22
12/12/2002US20020187511 Process for label-free measurement of modified substrate
12/12/2002US20020187510 Method for assay of antibodies and antibody assay device
12/12/2002US20020187509 Methods for detecting interaction between a test moiety and a plurality of target moieties
12/12/2002US20020187508 Analysis of preferential nucleotide sequences for use in human therapeutics; obtain nucleic acid sequences, incubate with cutting enzyme, expose to primers, amplify, evaluate for preferential genetic disorders
12/12/2002US20020187506 Syk localized at centrosome
12/12/2002US20020187504 Multifunctional magnetic nanowires
12/12/2002US20020187501 Microdevices having a preferential axis of magnetization and uses thereof
12/12/2002US20020187499 Kit for use in monitoring and treatment of endometriosis
12/12/2002US20020187498 Screening modulators of skin allergies; obtain sample, incubate with modulator, monitor and evaluate response
12/12/2002US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002US20020187491 Beta-adrenoceptor genetic polymorphisms and obesity
12/12/2002US20020187487 Detection of cancerous gastrointestinal disorders; obtain tissue sample, screen for expression of spasmolytic protein, presence of protein ndicates cancer
12/12/2002US20020187486 Detection of preferential nucleotide sequences in sample; obtain target nucleic acid sample, incubate with nucleases, expose to probes, detect preferential nucleotide sequences
12/12/2002US20020187485 Open substrate platforms suitable for analysis of biomolecules
12/12/2002US20020187484 Molecular break lights probes for detecting nucleotide cleavage
12/12/2002US20020187481 Detection of preferential particle in sample; obtain target, conjugate with reporter molecule, incubate with substrate, detect adjustment in substrate, adjustment in substrate indicates presence of preferential particle
12/12/2002US20020187480 Diagnostic method for assessing a condition of a performance animal
12/12/2002US20020187478 Detecting preferential particles in soluton; obtain apparatus, insert sample, monitor adjustments in volume
12/12/2002US20020187473 Polyamide nucleic acid derivatives, and agents and processes for preparing them
12/12/2002US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002US20020187468 Method and device for fixing micro-and/or nano-objects
12/12/2002US20020187466 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection